Internal Medicine, Hematology & Oncology · Duluth, GA
NPI
1992017362
Since 2010
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
3650 Steve Reynolds Blvd
Duluth, GA, 30096
Phone (404) 365-0966
Groups this clinician bills Medicare through
Medicare paid, 2024
$41K
1,940 services
Medicare patients, 2024
32
Average age 66
Drug cost, 2024
$6.9M
1,718 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Venkata K Pokuri prescribed most often to Medicare patients was Xtandi (Enzalutamide), with 115 prescriptions and refills. In total Venkata K Pokuri wrote 1,718 Medicare prescriptions that cost $6.9M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-12-28.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Xtandi Enzalutamide | 115 | 115 | 14 | $1.4M |
| Anastrozole Generic | 103 | 158 | 22 | $1,727 |
| Abiraterone Acetate Generic | 103 | 121 | 23 | $47K |
| Prednisone Generic | 81 | 136 | 23 | $605 |
| Dexamethasone Generic | 79 | 84 | 25 | $864 |
| Lenalidomide Generic | 72 | 72 | Under 11 | $904K |
| Nivestym Filgrastim-Aafi | 70 | 70 | 17 | $44K |
| Hydroxyurea Generic | 57 | 96 | Under 11 | $1,741 |
| Pradaxa Dabigatran Etexilate Mesylate | 55 | 111 | 17 | $11K |
| Ondansetron Odt Ondansetron | 47 | 47 | 27 | $522 |
| Xarelto Rivaroxaban | 46 | 102 | 14 | $47K |
| Prochlorperazine Maleate Generic | 39 | 39 | 22 | $506 |
| Letrozole Generic | 37 | 49 | Under 11 | $445 |
| Verzenio Abemaciclib | 36 | 36 | Under 11 | $579K |
| Granix Tbo-Filgrastim | 36 | 36 | 17 | $16K |
Brand drugs: 688 claims; generic drugs: 1,030 claims; opioid claims: 71.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Venkata K Pokuri were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.